STAND. COM. REP. NO. 597
Honolulu, Hawaii
, 2005
RE: H.B. No. 1051
H.D. 1
Honorable Calvin K.Y. Say
Speaker, House of Representatives
Twenty-Third State Legislature
Regular Session of 2005
State of Hawaii
Sir:
Your Committee on Health, to which was referred H.B. No. 1051 entitled:
"A BILL FOR AN ACT RELATING TO PRESCRIPTION DRUGS,"
begs leave to report as follows:
The purpose of this measure is to make clarifying amendments to the return-for-credit-and-reuse procedures for unused prescription drugs dispensed within health care institutions and for donation of previously dispensed prescription drugs.
Specifically, this measure would permit the return of drugs from in-use multiple dose containers, subject to appropriate safeguards, make the procedures for donation of prescription drugs similar to those for return-for-credit-and-reuse program, and make a variety of technical, nonsubstantive amendments.
Your Committee received testimony in support of the bill from the Medicine Bank. The Department of Health submitted testimony supporting the bill but expressing reservations.
Your Committee finds that the benefits of the return-for-credit-and-reuse program can be maximized if it is extended, with appropriate safeguards, to include return of drugs from in-use multiple dose containers. Your Committee further finds that applying the same safety standards to donation of prescription drugs as apply to the return-for-credit-and-reuse program will encourage donations and standardize procedures.
Your Committee has amended the bill by making it effective on July 1, 2020, in order to advance the bill for further discussion. Your Committee has also made one technical, nonsubstantive amendment.
As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 1051, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 1051, H.D. 1, and be referred to the Committee on Consumer Protection & Commerce.
Respectfully submitted on behalf of the members of the Committee on Health,
____________________________ DENNIS A. ARAKAKI, Chair |
||